Cargando…

Fatty Acid-Binding Protein 3 Expression in the Brain and Skin in Human Synucleinopathies

Parkinson’s disease (PD) and multiple system atrophy are types of adult-onset neurodegenerative disorders named synucleinopathies, which are characterized by prominent intracellular α-synuclein (αSyn) aggregates. We have previously found that αSyn aggregates and the vulnerability of dopaminergic neu...

Descripción completa

Detalles Bibliográficos
Autores principales:	Oizumi, Hideki, Yamasaki, Kenshi, Suzuki, Hiroyoshi, Hasegawa, Takafumi, Sugimura, Yoko, Baba, Toru, Fukunaga, Kohji, Takeda, Atsushi
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2021
Materias:	Neuroscience
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8026871/ https://www.ncbi.nlm.nih.gov/pubmed/33841128 http://dx.doi.org/10.3389/fnagi.2021.648982

Ejemplares similares

Phosphorylated alpha‐synuclein in Iba1‐positive macrophages in the skin of patients with Parkinson's disease
por: Oizumi, Hideki, et al.
Publicado: (2022)

Plasma sphingolipid abnormalities in neurodegenerative diseases
por: Oizumi, Hideki, et al.
Publicado: (2022)

Using Fatty Acid-Binding Proteins as Potential Biomarkers to Discriminate between Parkinson’s Disease and Dementia with Lewy Bodies: Exploration of a Novel Technique
por: Kawahata, Ichiro, et al.
Publicado: (2023)

Impact of Fatty Acid-Binding Proteins in α-Synuclein-Induced Mitochondrial Injury in Synucleinopathy
por: Cheng, An, et al.
Publicado: (2021)

Mechanisms of Neuronal Death in Synucleinopathy
por: Takeda, Atsushi, et al.
Publicado: (2006)

Suppression of dynamin GTPase decreases α-synuclein uptake by neuronal and oligodendroglial cells: a potent therapeutic target for synucleinopathy
por: Konno, Masatoshi, et al.
Publicado: (2012)

Pathogenic Impact of α-Synuclein Phosphorylation and Its Kinases in α-Synucleinopathies
por: Kawahata, Ichiro, et al.
Publicado: (2022)

Gut Microbiome-Modified Polyphenolic Compounds Inhibit α-Synuclein Seeding and Spreading in α-Synucleinopathies
por: Yamasaki, Tritia R., et al.
Publicado: (2020)

Glucocerebrosidase Involvement in Parkinson Disease and Other Synucleinopathies
por: Almeida, Maria do Rosário
Publicado: (2012)

Calcium: Alpha-Synuclein Interactions in Alpha-Synucleinopathies
por: Rcom-H'cheo-Gauthier, Alexandre N., et al.
Publicado: (2016)

Neuroinflammation and Glial Phenotypic Changes in Alpha-Synucleinopathies
por: Refolo, Violetta, et al.
Publicado: (2019)

Metallothionein, Copper and Alpha-Synuclein in Alpha-Synucleinopathies
por: Okita, Yuho, et al.
Publicado: (2017)

The link between neuroinflammation and the neurovascular unit in synucleinopathies
por: Wang, Qing, et al.
Publicado: (2023)

Risk of hospitalization in synucleinopathies and impact of psychosis
por: Piat, Capucine, et al.
Publicado: (2023)

Linking the Endoplasmic Reticulum to Parkinson’s Disease and Alpha-Synucleinopathy
por: Colla, Emanuela
Publicado: (2019)

Histone Deacetylase 6 and the Disease Mechanisms of α-Synucleinopathies
por: Lemos, Miguel, et al.
Publicado: (2020)

Nicotine-mediated effects in neuronal and mouse models of synucleinopathy
por: Fares, Mohamed Bilal, et al.
Publicado: (2023)

Skin Biopsy as a Diagnostic Tool for Synucleinopathies
por: Waqar, Sara, et al.
Publicado: (2023)

Dysregulated Lipid Metabolism and Its Role in α-Synucleinopathy in Parkinson’s Disease
por: Alecu, Irina, et al.
Publicado: (2019)

Neuroglial Senescence, α-Synucleinopathy, and the Therapeutic Potential of Senolytics in Parkinson’s Disease
por: Miller, Sean J., et al.
Publicado: (2022)

Reduced Cytosolic Calcium as an Early Decisive Cellular State in Parkinson’s Disease and Synucleinopathies
por: Betzer, Cristine, et al.
Publicado: (2018)

Is Ross Syndrome a New Type of Synucleinopathy? A Brief Research Report
por: Ma, Mingming, et al.
Publicado: (2020)

Real-Time Quaking- Induced Conversion Assays for Prion Diseases, Synucleinopathies, and Tauopathies
por: Vascellari, Sarah, et al.
Publicado: (2022)

Altered sleep and neurovascular dysfunction in alpha-synucleinopathies: the perfect storm for glymphatic failure
por: Buongiorno, Mariateresa, et al.
Publicado: (2023)

Do Patients With Parkinson’s Disease Exhibit Reduced Cheating Behavior? A Neuropsychological Study
por: Abe, Nobuhito, et al.
Publicado: (2018)

Cell-Type Specific Changes in DNA Methylation of SNCA Intron 1 in Synucleinopathy Brains
por: Gu, Jeffrey, et al.
Publicado: (2021)

Metabolic connectivity of resting-state networks in alpha synucleinopathies, from prodromal to dementia phase
por: Boccalini, Cecilia, et al.
Publicado: (2022)

Lovastatin Alleviates α-Synuclein Aggregation and Phosphorylation in Cellular Models of Synucleinopathy
por: Dai, Lijun, et al.
Publicado: (2021)

Alpha-Synuclein Strain Variability in Body-First and Brain-First Synucleinopathies
por: Just, Mie Kristine, et al.
Publicado: (2022)

Region-Specific Effects of Immunotherapy With Antibodies Targeting α-synuclein in a Transgenic Model of Synucleinopathy
por: Kallab, Martin, et al.
Publicado: (2018)

Chronic Caffeine Treatment Protects Against α-Synucleinopathy by Reestablishing Autophagy Activity in the Mouse Striatum
por: Luan, Yanan, et al.
Publicado: (2018)

Alpha-Synuclein in Skin Nerve Fibers as a Biomarker for Alpha-Synucleinopathies
por: Kim, Jee Young, et al.
Publicado: (2019)

Detection of Cerebrospinal Fluid Neurofilament Light Chain as a Marker for Alpha-Synucleinopathies
por: Canaslan, Sezgi, et al.
Publicado: (2021)

Lymphocyte Activation Gene 3 (Lag3) Contributes to α-Synucleinopathy in α-Synuclein Transgenic Mice
por: Gu, Hao, et al.
Publicado: (2021)

Development of α-Synuclein Real-Time Quaking-Induced Conversion as a Diagnostic Method for α-Synucleinopathies
por: Nakagaki, Takehiro, et al.
Publicado: (2021)

Clinical application of prion-like seeding in α-synucleinopathies: Early and non-invasive diagnosis and therapeutic development
por: Li, Jiaqi, et al.
Publicado: (2022)

Fatty Acid Binding Protein 5 Mediates Cell Death by Psychosine Exposure through Mitochondrial Macropores Formation in Oligodendrocytes
por: Cheng, An, et al.
Publicado: (2020)

Gaucher Disease and the Synucleinopathies
por: Hruska, Kathleen S., et al.
Publicado: (2006)

The Synucleinopathies: Twenty Years On
por: Goedert, Michel, et al.
Publicado: (2017)

Surgical Management of Synucleinopathies
por: Sriram, Sai, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_6ekhpb63d6o2qk90vl6l4pmp66